Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TFF1 anticorps (AA 57-84)

L’anticorps anti-TFF1 Monoclonal Souris est utilisé pour la détection de TFF1 dans des échantillons de Humain. Il a été validé pour IHC (p).
N° du produit ABIN3025059
642,40 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour TFF1 anticorps (AA 57-84) (ABIN3025059)

Antigène

Voir toutes TFF1 Anticorps
TFF1 (Trefoil Factor 1 (TFF1))

Reactivité

  • 142
  • 19
  • 18
  • 13
  • 11
Humain

Hôte

  • 78
  • 73
Souris

Clonalité

  • 104
  • 47
Monoclonal

Conjugué

  • 106
  • 9
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Cet anticorp TFF1 est non-conjugé

Application

  • 87
  • 54
  • 43
  • 35
  • 34
  • 20
  • 18
  • 15
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité

Carrier-free

Clone

SPM313
  • Épitope

    • 38
    • 35
    • 18
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 57-84

    Fonction

    Estrogen Inducible Protein pS2 Antibody / TFF1 (azide and preservative free)

    Séquence

    CFDDTVRGVP WCFYPNTIDV PPEEECEF

    Attributs du produit

    It recognizes a polypeptide of 6.5 kDa, identified as pS2 estrogen-regulated protein. Its epitope is localized between aa57-84 of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60 % of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy.

    Purification

    Protein G affinity chromatography

    Immunogène

    Amino acids CFDDTVRGVPWCFYPNTIDVPPEEECEF (aa57-84) from the human protein were used as the immunogen for the Estrogen Inducible Protein pS2 antibody.

    Isotype

    IgG1, kappa
  • Indications d'application

    Optimal dilution of the Estrogen Inducible Protein pS2 antibody should be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Agent conservateur

    Azide free

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store the Estrogen Inducible Protein pS2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Antigène

    TFF1 (Trefoil Factor 1 (TFF1))

    Autre désignation

    Estrogen Inducible Protein pS2

    Sujet

    It recognizes a polypeptide of 6.5 kDa, identified as pS2 estrogen-regulated protein. Its epitope is localized between aa57-84 of human pS2 protein. pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60 % of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. pS2 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract. Several studies have shown that pS2 is primarily expressed in estrogen receptor-positive breast tumors and it may define a subset of estrogen-dependent tumors that displays an increased likelihood of response to endocrine therapy.

    UniProt

    P04155

    Pathways

    EGFR Signaling Pathway
Vous êtes ici:
Chat with us!